GL1X · GenesisL1 explorer

Research workbench

Crystal structure of V30M mutated transthyretin in complex with 3- isomangostin

Analyse Crystal structure of V30M mutated transthyretin in complex with 3- isomangostin in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4Y9G
Type
protein
Length
231 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transthyretin
UniProt
P02766
Ligands
MKU
Pockets
1 · best druggability 0.34

Structure

x-ray diffraction · 2 distinct chains · 6% helix, 51% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATransthyretinprotein1166% helix, 51% strandP02766
BTransthyretinprotein1157% helix, 51% strandP02766

Ligands and binding sites

  • MKU · 5,9-dihydroxy-8-methoxy-2,2-dimethyl-7-(3-methylbut-2-en-1-yl)-3,4-dihydro-2H,6H-pyrano[3,2-b]xanthen-6-one · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1680.340.7616empty

Interfaces

1 interface between chains.

  • A–B · 920 Ų buried · 20 hydrogen bonds · protein-protein

Compared structures

  • 4Y9G · Crystal structure of V30M mutated transthyretin in complex with 3-isomangostin · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.